Pyrrolo[3,2-c]quinoline derivatives: A new class of kynurenine-3-hydroxylase inhibitors

Farmaco

Volumn 54, Issue 3, 1999, Pages 152-160

  Heidempergher, Franco ^a   Pevarello, Paolo ^a   Pillan, Antonio ^a   Pinciroli, Vittorio ^a   Della Torre, Arturo ^a   Speciale, Carmela ^a   Marconi, Marina ^a   Cini, Massimo ^a   Toma, Salvatore ^a   Greco, Felicita ^a   Varasi, Mario ^a  

^a PFIZER INC   (United States)

Author keywords

Enzyme inhibition; Hydroxylase; Kynurenine

Indexed keywords

KYNURENINE 3 MONOOXYGENASE; QUINOLONE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; MOLECULAR MODEL; NONHUMAN; RAT;

ANIMALS; ENZYME INHIBITORS; KYNURENINE 3-MONOOXYGENASE; LIVER; MIXED FUNCTION OXYGENASES; MOLECULAR STRUCTURE; PYRROLES; QUINOLINES; RATS;

EID: 0033620397     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00009-9     Document Type: Article

References (21)

1. Botting N.P. Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolism. Chem. Soc. Rev. 24:1995;401-412.
2. Saito K., Heyes M.P. Kynurenine pathway enzymes in brain: properties of enzymes and regulation of quinolinic acid synthesis. Adv. Exp. Med. Biol. (Recent Adv. Triptophan Res.). 398:1996;485-492.
3. Foster A.C., Vezzani A., French E.D., Schwarcz R. Kynurenic acid blocks neurotoxycity and seizures induced in rat by the related brain metabolite quinolinic acid. Neurosci. Lett. 48:1984;273-278.
4. Schwarcz R., Whetsell W.O., Mangano R.M. Quinolinic acid: an endogenous metabolite that causes axon-sparing lesions in rat brain. Science. 219:1983;316-318.
5. Saito K., Nowak T.S., Markey S.P., Heyes M.P. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J. Neurochem. 60:1993;180-192.
6. Pellicciari R., Natalini B., Costantino G., Mahmoud M.R., Mattoli L., Sadeghpour B.M. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J. Med. Chem. 37:1994;647-655.
7. Carpenedo R., Chiarugi A., Russi P., Lombardi G., Carla V., Pellicciari R., Mattoli L., Moroni F. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities. Neuroscience. 61:1994;237-244.
8. Speciale C., Varasi M., Cini M., Molinari A., Marconi M., Bormetti R., Caccia C., Curatolo L., Carfagna N., Wu H.Q., Schwarcz R. Multiple ways to modulate the content of quinolate and kynurenate in the central nervous system. Adv. Exp. Med. Biol. (Recent Adv. Triptophan Res.). 398:1996;512-517.
9. Miranda A.F., Boegman R.J., Beninger R.J., Jhamandas K. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience. 78:1997;967-975.
10. Giordani A., Corti L., Cini M., Bormetti R., Marconi M., Veneroni O., Speciale C., Varasi M. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase. Adv. Exp. Med. Biol. (Recent Adv. Triptophan Res.). 398:1996;531-534.
11. Popp F.D. Developments in the chemistry of Reissert compounds. Adv. Heterocycl. Chem. 24:1979;187.
12. Campbell K.N., Helbing C.H., Kervin J.F. Studies in the quinoline series. V. The preparation of some α-dialkylaminoethyl-2-quinolinemethanols. J. Am. Chem. Soc. 68:1946;1840-1843.
13. Heindel N.D., Bechara I.S., Kennewell P.D., Molnar J., Ohnmacht C.J., Lenke S.M., Lenke T.F. Cyclization of aniline-acetylenedicarboxylate adducts. A modified Conrad-Limpach method for the synthesis of potential antimalarials. J. Med. Chem. 11:1968;1218-1221.
14. R. Gordon, R. McWright, A simple one-pot conversion of alkyl 4-oxo-1,4-dihydroquinoline-2-carboxylates to 4-aminoquinoline-2-carboxylates using reactive isocyanates, Synthesis (1984) 1058-1061.
15. Giordani A., Pevarello P., Cini M., Bormetti R., Greco F., Toma S., Speciale C., Varasi M. 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase. BioMed. Chem. Lett. 8:1998;2907-2912.
16. Röver S., Cesura A.M., Huguenin P., Kettler R., Szente A. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J. Med. Chem. 40:1997;4378-4385.
17. Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.J.P. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107:1985;3902-3909.
18. Khan M.A., Ferreira da Rocha J. Tricyclic heteroaromatic system II (1). A convenient synthesis of 1H-pyrrolo[3,2-c]quinolines (2a, b). J. Heterocycl. Chem. 15:1978;913-921.
19. 3H]kynurenine. Analyt. Biochem. 205:1992;257-262.
20. Takikawa O., Yoshida R., Kydo R., Hayashi O. Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 261:1986;3648-3653.
21. Okuno E., Schmidt W., Parks D.A., Nakamura M., Schwarcz R. Measurement of rat brain kynurenine aminotransferase at physiological conditions. J. Neurochem. 57:1991;533-540.